Centiva Capital’s Jackson Acquisition Company Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 RJAC.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-74,950
Closed -$11K 1987
2022
Q2
$11K Hold
74,950
﹤0.01% 1536
2022
Q1
$15K Buy
+74,950
New +$26.7K ﹤0.01% 1507

Other funds holding RJAC.WS

Centiva Capital's RJAC.WS Position: Q3 2022 in Review

Centiva Capital sold out of Jackson Acquisition Company Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 (RJAC.WS) in Q3 2022, closing a stake of 74,950 shares — an estimated $11K sold.

Centiva Capital first reported a position in RJAC.WS in Q1 2022 and held it in 2 quarters. The position peaked at $15K in Q1 2022. 36 funds tracked by Wall St. Rank hold RJAC.WS as of Q3 2022.

  • Centiva Capital reported no remaining Jackson Acquisition Company Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 position as of Q3 2022 after selling out during the quarter.
  • Centiva Capital sold 74,950 Jackson Acquisition Company Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 shares in Q3 2022, an estimated $11K.
  • Centiva Capital first reported a position in Jackson Acquisition Company Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 in Q1 2022 and held it in 2 quarters.
  • Centiva Capital's Jackson Acquisition Company Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 position peaked at $15K in Q1 2022.
  • 36 funds tracked by Wall St. Rank held Jackson Acquisition Company Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 as of Q3 2022.

Based on Centiva Capital's 13F filing for Q3 2022, filed 14 Nov 2022.